CA2873138A1 - Compositions et methodes de traitement de la douleur locale - Google Patents

Compositions et methodes de traitement de la douleur locale Download PDF

Info

Publication number
CA2873138A1
CA2873138A1 CA2873138A CA2873138A CA2873138A1 CA 2873138 A1 CA2873138 A1 CA 2873138A1 CA 2873138 A CA2873138 A CA 2873138A CA 2873138 A CA2873138 A CA 2873138A CA 2873138 A1 CA2873138 A1 CA 2873138A1
Authority
CA
Canada
Prior art keywords
pain
pharmaceutical composition
administration
compositions
bupivacaine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2873138A
Other languages
English (en)
Inventor
Mahesh Kandula
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cellix Bio Pvt Ltd
Original Assignee
Cellix Bio Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellix Bio Pvt Ltd filed Critical Cellix Bio Pvt Ltd
Publication of CA2873138A1 publication Critical patent/CA2873138A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA2873138A 2012-05-10 2013-02-16 Compositions et methodes de traitement de la douleur locale Abandoned CA2873138A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1843CH2012 2012-05-10
IN1843/CHE/2012 2012-05-10
PCT/IB2013/051268 WO2013168006A2 (fr) 2012-05-10 2013-02-16 Compositions et méthodes de traitement de la douleur locale

Publications (1)

Publication Number Publication Date
CA2873138A1 true CA2873138A1 (fr) 2013-11-14

Family

ID=54193695

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2873138A Abandoned CA2873138A1 (fr) 2012-05-10 2013-02-16 Compositions et methodes de traitement de la douleur locale

Country Status (8)

Country Link
EP (1) EP2882745A2 (fr)
JP (1) JP2016508956A (fr)
CN (1) CN105612155A (fr)
AU (1) AU2013257727B2 (fr)
CA (1) CA2873138A1 (fr)
SG (1) SG11201407323WA (fr)
WO (1) WO2013168006A2 (fr)
ZA (1) ZA201408055B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8361067B2 (en) 2002-09-30 2013-01-29 Relievant Medsystems, Inc. Methods of therapeutically heating a vertebral body to treat back pain
US10588691B2 (en) 2012-09-12 2020-03-17 Relievant Medsystems, Inc. Radiofrequency ablation of tissue within a vertebral body
IL238516B (en) 2012-11-05 2022-08-01 Relievant Medsystems Inc System and methods for creating curved pathways through bone and regulating the nerves within the bone
US9724151B2 (en) 2013-08-08 2017-08-08 Relievant Medsystems, Inc. Modulating nerves within bone using bone fasteners
IL290150B2 (en) * 2016-12-26 2024-03-01 Cellix Bio Private Ltd Compounds and methods for treating chronic pain
WO2021050767A1 (fr) 2019-09-12 2021-03-18 Relievant Medsystems, Inc. Systèmes et méthodes de modulation de tissu

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use
CN1187813A (zh) * 1995-05-01 1998-07-15 斯科舍集团有限公司 作为生物活性化合物的脂肪酸酯
GB9704349D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
PT1032390E (pt) * 1997-11-19 2004-04-30 Darwin Discovery Ltd Formulacao anestesica
US7560442B2 (en) * 2001-04-30 2009-07-14 Trommsdorff Gmbh & Co. Kg Arzneimittel Pharmaceutically active uridine esters
US8920843B2 (en) * 2007-11-07 2014-12-30 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
US8846068B2 (en) * 2008-04-18 2014-09-30 Warsaw Orthopedic, Inc. Methods and compositions for treating post-operative pain comprising a local anesthetic
US20120022147A1 (en) * 2011-08-17 2012-01-26 Krisani Biosciences (P) Ltd 2, 6 xylidine derivatives for the treatment of pain

Also Published As

Publication number Publication date
ZA201408055B (en) 2016-03-30
WO2013168006A2 (fr) 2013-11-14
EP2882745A2 (fr) 2015-06-17
AU2013257727B2 (en) 2016-04-28
WO2013168006A3 (fr) 2016-09-01
JP2016508956A (ja) 2016-03-24
CN105612155A (zh) 2016-05-25
SG11201407323WA (en) 2014-12-30
AU2013257727A1 (en) 2014-11-27

Similar Documents

Publication Publication Date Title
WO2013167993A1 (fr) Compositions et méthodes de traitement de troubles neurologiques dégénératifs
WO2013167988A1 (fr) Compositions et méthodes de traitement de la toux
US9492409B2 (en) Compositions and methods for the treatment of local pain
CA2873138A1 (fr) Compositions et methodes de traitement de la douleur locale
WO2014115098A1 (fr) Compositions et procédés pour le traitement de maladies neurologiques et d'une inflammation
US9108942B1 (en) Compositions and methods for the treatment of moderate to severe pain
AU2013285126A1 (en) Compositions and methods for the treatment of moderate to severe pain
AU2013257706A1 (en) Compositions and methods for the treatment of neurological disorders
WO2013168011A1 (fr) Compositions et méthodes de traitement de la douleur chronique
AU2013257710B2 (en) Compositions and methods for the treatment of neurological disorders
WO2013168008A1 (fr) Compositions et méthodes de traitement d'affections neurologiques
US9346742B2 (en) Compositions and methods for the treatment of fibromyalgia pain
WO2014057439A2 (fr) Compositions et procédés de traitement de maladies neurologiques et des complications associées
WO2013168002A1 (fr) Compositions et méthodes de traitement d'affections neurologiques
WO2013168012A1 (fr) Compositions et méthodes de traitement de troubles respiratoires
EP3344239A1 (fr) Compositions et méthodes pour le traitement de la maladie de parkinson
US9173877B1 (en) Compositions and methods for the treatment of local pain
US20150087674A1 (en) Compositions and methods for the treatment of severe pain
US9227974B2 (en) Compositions and methods for the treatment of respiratory disorders
US20150141384A1 (en) Compositions and methods for the treatment of neurological degenerative disorders
WO2013168025A1 (fr) Compositions et méthodes de traitement des maladies de coagulation du sang
WO2013168001A1 (fr) Compositions et méthodes de traitement de la douleur modérée à sévère
WO2013168015A1 (fr) Compositions et méthodes pour le traitement de l'asthme et de l'allergie
WO2014195849A2 (fr) Composition et méthodes de traitement de maladies cérébrovasculaires
WO2014060941A2 (fr) Compositions d'agents neuroprotecteurs et procédés correspondants destinés au traitement de maladies neurologiques et neurodégénératives

Legal Events

Date Code Title Description
FZDE Dead

Effective date: 20180216